| Purine metabolism |    |
| Nitrogen metabolism |    |
| Glycine, serine and threonine metabolism |    |
| Alanine, aspartate and glutamate metabolism |    |
| Selenocompound metabolism |    |
| Arginine and proline metabolism |    |
| Phenylalanine metabolism |    |
| pentose phosphate pathway |    |
| Pyruvate metabolism |    |
| Nicotinate and nicotinamide metabolism |    |
| Propanoate metabolism |    |
| Citrullinemia Type I |    |
| Carbamoyl Phosphate Synthetase Deficiency |    |
| Argininosuccinic Aciduria |    |
| Phenylalanine and Tyrosine Metabolism |    |
| Cysteine Metabolism |    |
| Transcription/Translation |    |
| Pantothenate and CoA Biosynthesis |    |
| Methionine Metabolism |    |
| Histidine metabolism |    |
| Fatty acid Metabolism |    |
| Urea Cycle |    |
| Aspartate Metabolism |    |
| Riboflavin Metabolism |    |
| Glutamate Metabolism |    |
| Butyrate Metabolism |    |
| Thiamine Metabolism |    |
| 2-Hydroxyglutric Aciduria (D And L Form) |    |
| Adenosine Deaminase Deficiency |    |
| Adenylosuccinate Lyase Deficiency |    |
| AICA-Ribosiduria |    |
| Canavan Disease |    |
| Cystathionine Beta-Synthase Deficiency |    |
| Dihydropyrimidine Dehydrogenase Deficiency (DHPD) |    |
| Ethylmalonic Encephalopathy |    |
| Glutaric Aciduria Type I |    |
| Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) |    |
| Histidinemia |    |
| Hypoacetylaspartia |    |
| Leigh Syndrome |    |
| Malonic Aciduria |    |
| Methylmalonic Aciduria Due to Cobalamin-Related Disorders |    |
| Molybdenum Cofactor Deficiency |    |
| Ornithine Transcarbamylase Deficiency (OTC Deficiency) |    |
| Phenylketonuria |    |
| Prolidase Deficiency (PD) |    |
| Prolinemia Type II |    |
| Purine Nucleoside Phosphorylase Deficiency |    |
| Pyruvate Dehydrogenase Complex Deficiency |    |
| S-Adenosylhomocysteine (SAH) Hydrolase Deficiency |    |
| Xanthine Dehydrogenase Deficiency (Xanthinuria) |    |
| Methionine Adenosyltransferase Deficiency |    |
| Glycine N-methyltransferase Deficiency |    |
| Non Ketotic Hyperglycinemia |    |
| Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency) |    |
| Dimethylglycine Dehydrogenase Deficiency |    |
| 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency |    |
| Sarcosinemia |    |
| Azithromycin Action Pathway |    |
| Clarithromycin Action Pathway |    |
| Clindamycin Action Pathway |    |
| Erythromycin Action Pathway |    |
| Roxithromycin Action Pathway |    |
| Telithromycin Action Pathway |    |
| Amikacin Action Pathway |    |
| Gentamicin Action Pathway |    |
| Kanamycin Action Pathway |    |
| Neomycin Action Pathway |    |
| Netilmicin Action Pathway |    |
| Spectinomycin Action Pathway |    |
| Streptomycin Action Pathway |    |
| Clomocycline Action Pathway |    |
| Demeclocycline Action Pathway |    |
| Doxycycline Action Pathway |    |
| Minocycline Action Pathway |    |
| Oxytetracycline Action Pathway |    |
| Tetracycline Action Pathway |    |
| Lymecycline Action Pathway |    |
| Lactic Acidemia |    |
| Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency) |    |
| Hyperinsulinism-Hyperammonemia Syndrome |    |
| Methylenetetrahydrofolate Reductase Deficiency (MTHFRD) |    |
| Hypermethioninemia |    |
| Pyruvate Carboxylase Deficiency |    |
| Primary Hyperoxaluria Type I |    |
| Argininemia |    |
| Hyperprolinemia Type II |    |
| Hyperprolinemia Type I |    |
| Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) |    |
| Ornithine Aminotransferase Deficiency (OAT Deficiency) |    |
| Lesch-Nyhan Syndrome (LNS) |    |
| Gout or Kelley-Seegmiller Syndrome |    |
| Tyrosinemia Type 2 (or Richner-Hanhart syndrome) |    |
| Tyrosinemia Type 3 (TYRO3) |    |
| Homocarnosinosis |    |
| Azathioprine Action Pathway |    |
| Mercaptopurine Action Pathway |    |
| Disulfiram Action Pathway |    |
| Thioguanine Action Pathway |    |
| Ethanol Degradation |    |
| Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids |    |
| Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids |    |
| Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids |    |
| Dimethylglycine Dehydrogenase Deficiency |    |
| Hyperglycinemia, non-ketotic |    |
| Beta-mercaptolactate-cysteine disulfiduria |    |
| Malonyl-coa decarboxylase deficiency |    |
| Creatine deficiency, guanidinoacetate methyltransferase deficiency |    |
| Hyperornithinemia with gyrate atrophy (HOGA) |    |
| Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome] |    |
| L-arginine:glycine amidinotransferase deficiency |    |
| Xanthinuria type I |    |
| Xanthinuria type II |    |
| Glucose-6-phosphate dehydrogenase deficiency |    |
| Ribose-5-phosphate isomerase deficiency |    |
| Transaldolase deficiency |    |
| Adenine phosphoribosyltransferase deficiency (APRT) |    |
| Mitochondrial DNA depletion syndrome |    |
| Myoadenylate deaminase deficiency |    |
| Carnitine palmitoyl transferase deficiency (I) |    |
| Long chain acyl-CoA dehydrogenase deficiency (LCAD) |    |
| Very-long-chain acyl coa dehydrogenase deficiency (VLCAD) |    |
| Carnitine palmitoyl transferase deficiency (II) |    |
| Medium chain acyl-coa dehydrogenase deficiency (MCAD) |    |
| Trifunctional protein deficiency |    |
| Primary hyperoxaluria II, PH2 |    |
| Pyruvate kinase deficiency |    |
| Succinic semialdehyde dehydrogenase deficiency |    |
| Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD) |    |
| Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type |    |
| Mercaptopurine Metabolism Pathway |    |
| Valproic Acid Metabolism Pathway |    |
| Tobramycin Action Pathway |    |
| Tigecycline Action Pathway |    |
| Arbekacin Action Pathway |    |
| Paromomycin Action Pathway |    |
| 3-Phosphoglycerate dehydrogenase deficiency |    |
| Cystinosis, ocular nonnephropathic |    |
| Rolitetracycline Action Pathway |    |
| Methacycline Action Pathway |    |
| Lincomycin Action Pathway |    |
| Chloramphenicol Action Pathway |    |
| Troleandomycin Action Pathway |    |
| Josamycin Action Pathway |    |
| Abacavir Action Pathway |    |
| Delavirdine Action Pathway |    |
| Didanosine Action Pathway |    |
| Efavirenz Action Pathway |    |
| Emtricitabine Action Pathway |    |
| Lamivudine Action Pathway |    |
| Nevirapine Action Pathway |    |
| Rilpivirine Action Pathway |    |
| Stavudine Action Pathway |    |
| Zalcitabine Action Pathway |    |
| Zidovudine Action Pathway |    |
| Acylcarnitine 3-Hydroxydecanoylcarnitine |    |
| Acylcarnitine (7Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-7,9,12,15,18,21-hexaenoylcarnitine |    |
| Acylcarnitine Pentacosanoylcarnitine |    |
| Acylcarnitine Hexacosanoylcarnitine |    |
| Acylcarnitine (17Z)-Hexacos-17-enoylcarnitine |    |
| Acylcarnitine (13Z,16Z)-Hexacosa-13,16-dienoylcarnitine |    |
| Acylcarnitine Heptacosanoylcarnitine |    |
| Acylcarnitine Octacosanoylcarnitine |    |
| Acylcarnitine Nonacosanoylcarnitine |    |
| Acylcarnitine (2S,3R)-3-Hydroxy-2-methylbutanoylcarnitine |    |
